An Escherichia coli O157-Specific Engineered Pyocin Prevents and Ameliorates Infection by E. coli O157:H7 in an Animal Model of Diarrheal Disease

Antimicrobial and Antimotility Agent Use in Persons with Shiga Toxin-Producing Escherichia coli O157 Infection in FoodNet Sites

(2011) J. M. Nelson et al.   CLINICAL INFECTIOUS DISEASES

Distinct Physiologic and Inflammatory Responses Elicited in Baboons after Challenge with Shiga Toxin Type 1 or 2 from Enterohemorrhagic Escherichia coli

(2010) D. J. Stearns-Kurosawa et al.   INFECTION AND IMMUNITY

Microencapsulation of budesonide with dextran by spray drying technique for colon-targeted delivery: anin vitro/in vivoevaluation in induced colitis in rat

(2010) Jaleh Varshosaz et al.   JOURNAL OF MICROENCAPSULATION

Escherichia coli O157

(2010) Hugh Pennington   LANCET

An Engineered R-Type Pyocin Is a Highly Specific and Sensitive Bactericidal Agent for the Food-Borne Pathogen Escherichia coli O157:H7

(2009) D. Scholl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibacterial Efficacy of R-Type Pyocins towards Pseudomonas aeruginosa in a Murine Peritonitis Model

(2008) D. Scholl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Retargeting R-Type Pyocins To Generate Novel Bactericidal Protein Complexes

(2008) S. R. Williams et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Renal damage and death in weaned mice after oral infection with Shiga toxin 2-producingEscherichia colistrains

(2008) R. J. F. Brando et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Mouse Model of Hemolytic-Uremic Syndrome Caused by Endotoxin-Free Shiga Toxin 2 (Stx2) and Protection from Lethal Outcome by Anti-Stx2 Antibody

(2008) K. A. D. Sauter et al.   INFECTION AND IMMUNITY

Type 2 Secretion Promotes Enterohemorrhagic Escherichia coli Adherence and Intestinal Colonization

(2008) T. D. Ho et al.   INFECTION AND IMMUNITY